Chitinase-3 (Recombinant)

Recombinant Protein · expressed in HEK293
Citation tracking pending
Recombinant human Chitinase-3 (YKL-40; UniProt Q53FH2), expressed in HEK293 cells. Suitable for enzymatic characterisation, inhibitor screening, binding studies, and antibody validation as a positive control standard.
Expression system
HEK293
Cat. #
REC-Chitinase3

In stock

SKU
REC-Chitinase3
$498.00

Target Overview

Chitinase-3-like protein 1 — commonly referred to as YKL-40, CHI3L1, or HC gp-39 — is a secreted glycoprotein of 378 amino acids (UniProt Q53FH2) belonging to the glycosyl hydrolase family 18. Despite its structural homology to chitinases, Chitinase-3 lacks detectable chitinolytic enzymatic activity in humans due to substitutions at key catalytic residues; it binds chitin oligosaccharides and a range of extracellular matrix components, including heparin, heparan sulfate, and collagen. The protein is produced predominantly by macrophages, neutrophils, synoviocytes, and astrocytes in response to inflammatory stimuli. This recombinant is expressed in HEK293 mammalian cells, which provides glycosylation patterns closely reflecting those of the endogenous human protein — an important consideration for binding assays, receptor interaction studies, and antibody epitope validation where post-translational modifications may influence recognition. The full-length mature sequence spans 378 residues following signal peptide cleavage. In a research context, this recombinant is routinely used to establish dose-response curves in sandwich ELISA development, as a calibration standard for cerebrospinal fluid or synovial fluid quantification assays, and as a positive control antigen for Western blot and immunohistochemistry antibody validation. Researchers designing inhibitor screens targeting CHI3L1–receptor interactions (e.g., IL-13Rα2, CRTH2) use the recombinant as the binding partner in surface plasmon resonance and biolayer interferometry formats. Investigators working on sepsis, neurodegeneration, or synovial biology who require a well-characterised source of human YKL-40 protein for in vitro stimulation or pull-down experiments will find this HEK293-expressed form suitable for those applications. Researchers validating anti-Chitinase-3 antibodies can pair this recombinant directly with the Triple Point Biologics matched antibody (SKU: RP-Chitinase3), available on the linked product page.

Background

Chitinase-3-like protein 1 (CHI3L1/YKL-40) has emerged as one of the more extensively studied secreted glycoproteins in inflammation, neurodegeneration, and joint disease research over the past two decades. The protein is constitutively secreted at low levels by tissue macrophages and chondrocytes, but expression is markedly upregulated in response to IL-6, IL-13, TNF-α, and hypoxia — making it a sensitive biochemical indicator of tissue remodelling and inflammatory activation in experimental systems. In the context of neurological disease research, CHI3L1 has been studied as a cerebrospinal fluid (CSF) and saliva biomarker of glial activation. Sha et al. (2026, PeerJ) reviewed the role of YKL-40 in Alzheimer's disease pathology, noting its expression by reactive astrocytes in plaque-adjacent tissue and its potential relevance as a target in drug development studies. Separately, Castelli et al. (2026, Sci Rep) demonstrated that YKL-40 is detectable in saliva of individuals with multiple sclerosis, with salivary concentrations correlating with CSF levels — a finding relevant to researchers developing minimally invasive sampling protocols for neuroinflammatory biomarker assays. Eckerström et al. (2026, Ticks Tick Borne Dis) investigated YKL-40 as part of a CSF biomarker panel in tick-borne encephalitis, further illustrating the use of recombinant CHI3L1 standards in quantitative neuroimmunological assays. In rheumatology research, CHI3L1 expression has been characterised within synovial tissue. Khmelevskaya et al. (2026, J Rheumatol) used single-cell and spatial omics to map disease-specific synovial cell landscapes in rheumatoid and psoriatic arthritis, identifying CHI3L1-expressing cell populations as part of the inflammatory synovial microenvironment. This type of study benefits from recombinant protein standards for correlating transcriptomic signal with secreted protein quantification. In sepsis research, Wei et al. (2026, Cent Eur J Immunol) reported that lactylation of CHI3L1 promotes sepsis progression in experimental models — demonstrating that post-translational modifications of the protein itself are an active area of mechanistic investigation, and underscoring the relevance of a mammalian-expressed recombinant that faithfully recapitulates the native modified form. Across these research areas, the recombinant protein is used primarily as a quantitative standard, a binding-assay component, and an in vitro stimulation reagent rather than as a direct enzymatic reagent, consistent with the lectin-like rather than hydrolase functional profile of human CHI3L1.

Applications

  • Quantitative ELISA calibration standard for CHI3L1 measurement in CSF, synovial fluid, or saliva matrices
  • Antibody validation positive control for Western blot using matched Triple Point antibody RP-Chitinase3
  • Surface plasmon resonance (SPR) or biolayer interferometry (BLI) binding studies with CHI3L1 receptor candidates (e.g., IL-13Rα2, CRTH2)
  • Chitin oligosaccharide binding assay to characterise lectin-domain interactions
  • In vitro macrophage or fibroblast stimulation to study downstream signalling responses to exogenous YKL-40
  • Pull-down or co-immunoprecipitation experiments to identify novel CHI3L1 binding partners in cell lysates
  • Inhibitor competition assay to evaluate small-molecule or antibody-mediated blockade of CHI3L1–receptor interactions

References

  1. Sha Y et al. The role of YKL-40 in Alzheimer's disease pathology and drug targeting. PeerJ. 2026. doi:10.7717/peerj.21361 PMID: 42291413
  2. Castelli B et al. Neurodegenerative and inflammatory biomarkers are detectable in saliva in multiple sclerosis. Sci Rep. 2026. doi:10.1038/s41598-026-51273-9 PMID: 42215518
  3. Eckerström M et al. Cognitive outcome in relation to cerebrospinal fluid markers of neuronal and glial cell damage: A prospective study of tick-borne encephalitis. Ticks Tick Borne Dis. 2026. doi:10.1016/j.ttbdis.2026.102673 PMID: 42314471
  4. Khmelevskaya A et al. Single-Cell and Spatial Omics Uncover Disease-Specific Synovial Landscapes in Rheumatoid and Psoriatic Arthritis. J Rheumatol. 2026. doi:10.3899/jrheum.2026-0375 PMID: 42297438
  5. Wei S et al. Lactylated chitinase-3-like protein 1 promotes the development of sepsis. Cent Eur J Immunol. 2026. doi:10.5114/ceji/204065 PMID: 42245123

Additional Specifications

Storage Buffer 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol
Endotoxin Level <0.1 EU/µg by LAL
Purity (%) >90% by SDS-PAGE
Expression System HEK293
Subcellular Localization Secreted; macrophage/neutrophil granules

Frequently Asked Questions

What molecular weight does recombinant Chitinase-3 / YKL-40 run at on SDS-PAGE?

The mature Chitinase-3 (CHI3L1) sequence is 378 amino acids, giving a predicted unglycosylated MW of ~42 kDa. Because this recombinant is expressed in HEK293 cells, N-linked glycosylation adds roughly 8–12 kDa, so the dominant band on reducing SDS-PAGE typically appears at 50–55 kDa. A faint higher-MW smear is occasionally visible and reflects heterogeneous glycoforms — consistent with endogenous YKL-40 behavior. If you are comparing to a deglycosylated control, PNGase F treatment collapses the band to the expected ~42 kDa core.

Does recombinant Chitinase-3 have chitinolytic enzyme activity, and how do I confirm it is active?

Human CHI3L1 lacks chitinolytic activity; critical catalytic residues present in active chitinases (most notably Glu140 in family 18) are substituted in CHI3L1, abolishing hydrolysis of the glycosidic bond. Activity is therefore assessed by chitin-oligosaccharide or heparin binding, not by 4-MU–chitotrioside fluorescence assays used for chitotriosidase or AMCase. A standard pull-down with chitin-agarose beads in 50 mM Tris-HCl pH 7.5, 150 mM NaCl serves as a functional binding confirmation. Do not use 4-methylumbelliferyl substrates — a flat fluorescence curve is expected and does not indicate a defective lot.

What assay format and binding conditions work best for Chitinase-3 heparin or ECM interaction studies?

For heparin-binding assays, a heparin-Sepharose pull-down or SPR experiment in 50 mM Tris-HCl pH 7.5, 150 mM NaCl is a reliable starting point; elution typically requires 0.5–1.0 M NaCl, consistent with published heparin-binding data for YKL-40. For ELISA-based receptor or collagen binding, coat recombinant Chitinase-3 at 0.5–2 µg/mL. Starting protein concentrations of 100–500 nM are appropriate for solution-phase binding assays. Calcium and magnesium are not required for ECM binding, and the standard storage buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol) is compatible with most assay formats after a 1:5 or greater dilution.

What is the isoform and processing state of this recombinant — does it include the signal peptide?

This recombinant corresponds to the full-length mature secreted form of human CHI3L1 (UniProt Q53FH2), with the 21-amino-acid signal peptide removed, spanning residues 22–383 of the canonical sequence (378 residues of mature protein). No propeptide cleavage is required for secretion or function. The HEK293 expression system faithfully replicates the endogenous secreted glycoprotein, making it suitable for studies where post-translational modifications — particularly N-glycosylation at Asn60 and Asn233 — are relevant to receptor binding or antibody epitope accessibility.

Can I use Chitinase-3 (Recombinant) as a positive control for Western blot with the RP-Chitinase3 antibody?

Yes — this is a primary use case. Load 20–50 ng of recombinant Chitinase-3 per lane alongside your cell lysate or conditioned medium samples. The matched rabbit polyclonal RP-Chitinase3 (/anti-chitinase-3-rabbit-polyclonal-antibody) is raised against the same recombinant, ensuring band concordance at 50–55 kDa on Western blot. This pairing eliminates the guesswork of mismatched band positions between recombinant positive control and antibody epitope. Because both products are produced from the same TPB lot pipeline, batch-to-batch consistency between the antibody and this recombinant is routinely monitored.

How much recombinant Chitinase-3 should I load for a Western blot positive control lane?

A loading range of 20–50 ng per lane is sufficient for a clear single band at 50–55 kDa using the RP-Chitinase3 rabbit polyclonal at a 1:1,000–1:2,000 dilution with standard HRP-conjugated secondary antibody and ECL detection. At 100 ng the band saturates on most film or digital imagers, which is useful for troubleshooting but not for quantitative comparisons. Dilute the recombinant stock in 1× SDS sample buffer immediately before use; do not pre-dilute in PBS and store, as glycoprotein adsorption to low-binding tubes can reduce apparent loading.

How should I handle, dilute, and store recombinant Chitinase-3 to maximize shelf life?

The protein is supplied in 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol and stored at −20°C in single-use aliquots. Avoid repeated freeze-thaw cycles — activity and binding integrity decline noticeably after three or more cycles. Thaw on ice, spin briefly at 10,000 × g to collect any microdroplets, and use within 24 hours of thawing. For dilution into assay buffer, maintain at least 0.1 mg/mL BSA as a carrier if working below 10 µg/mL to prevent surface adsorption losses. Properly aliquoted and stored stocks are stable for 12 months at −20°C.

Is recombinant Chitinase-3 suitable for ELISA standard curve generation and what concentration range should I use?

This recombinant is appropriate as a calibration standard for sandwich ELISAs targeting human YKL-40/CHI3L1, provided your capture and detection antibodies recognize the glycosylated form — which the HEK293-expressed material accurately reflects. A typical standard curve spans 0.1–100 ng/mL in a matched assay diluent (e.g., 1% BSA in PBS-T). Prepare the top standard fresh from a thawed aliquot and perform serial 2- or 3-fold dilutions. Endotoxin is <0.1 EU/µg by LAL, so this recombinant is also suitable for cell-based stimulation assays where LPS contamination would confound cytokine readouts.

Validation imagery coming soon

Western blot validation figures for REC-Chitinase3 will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →